Trial · NCT01920711
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Cumulative Number of Primary Composite Events of Cardiovascular (CV) Death and Total (First and Recurrent) HF Hospitalizations. | LCZ696 | Primary Composite Events | 894 | Events | |
| Cumulative Number of Primary Composite Events of Cardiovascular (CV) Death and Total (First and Recurrent) HF Hospitalizations. | Valsartan | Primary Composite Events | 1009 | Events | |
| Cumulative Number of Primary Composite Events of Cardiovascular (CV) Death and Total (First and Recurrent) HF Hospitalizations. | LCZ696 | Total Hospitalizations for heart failure | 690 | Events | |
| Cumulative Number of Primary Composite Events of Cardiovascular (CV) Death and Total (First and Recurrent) HF Hospitalizations. | Valsartan | Total Hospitalizations for heart failure | 797 | Events | |
| Cumulative Number of Primary Composite Events of Cardiovascular (CV) Death and Total (First and Recurrent) HF Hospitalizations. | LCZ696 | Cardiovascular death | 204 | Events | |
| Cumulative Number of Primary Composite Events of Cardiovascular (CV) Death and Total (First and Recurrent) HF Hospitalizations. | Valsartan | Cardiovascular death | 212 | Events | |
| Change in the Clinical Summary Score From Baseline to Month 8 by Kansas City Cardiomyopathy Questionnaire (KCCQ) | LCZ696 | -1.5073 | Standard Error 0.3709 | Points on a scale | |
| Change in the Clinical Summary Score From Baseline to Month 8 by Kansas City Cardiomyopathy Questionnaire (KCCQ) | Valsartan | -2.5338 | Standard Error 0.3729 | Points on a scale | |
| Change From Baseline to Month 8 in New York Heart Association (NYHA) Functional Class | LCZ696 | Improved (n=2316, 2302) | 347 | Number of Participants | |
| Change From Baseline to Month 8 in New York Heart Association (NYHA) Functional Class | Valsartan | Improved (n=2316, 2302) | 289 | Number of Participants | |
| Change From Baseline to Month 8 in New York Heart Association (NYHA) Functional Class | LCZ696 | Unchanged (n=2316, 2302) | 1767 | Number of Participants | |
| Change From Baseline to Month 8 in New York Heart Association (NYHA) Functional Class | Valsartan | Unchanged (n=2316, 2302) | 1792 | Number of Participants | |
| Change From Baseline to Month 8 in New York Heart Association (NYHA) Functional Class | LCZ696 | Worsened (n=2316, 2302) | 202 | Number of Participants | |
| Change From Baseline to Month 8 in New York Heart Association (NYHA) Functional Class | Valsartan | Worsened (n=2316, 2302) | 221 | Number of Participants | |
| Participants With First Occurrence of a Composite Renal Endpoint | LCZ696 | Composite renal endpoint | 33 | Participants | |
| Participants With First Occurrence of a Composite Renal Endpoint | Valsartan | Composite renal endpoint | 64 | Participants | |
| Participants With First Occurrence of a Composite Renal Endpoint | LCZ696 | Renal Death | 1 | Participants | |
| Participants With First Occurrence of a Composite Renal Endpoint | Valsartan | Renal Death | 1 | Participants | |
| Participants With First Occurrence of a Composite Renal Endpoint | LCZ696 | Reaching ESRD | 7 | Participants | |
| Participants With First Occurrence of a Composite Renal Endpoint | Valsartan | Reaching ESRD | 12 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01920711/results